Detailed Programme
5 July 2026 |
|||
|
13:00–19:00 |
Registration |
||
|
Presidential Lounge |
13:00 |
ICO Board Meeting |
|
5 July 2026 – Opening Ceremony |
|||
Drama Hall |
16:00–16:30 |
||
5 July 2026 – Awards |
|||
|
Drama Hall |
Chair: Carmen Galan |
16:30–17:15 |
The Roy L. Whistler International Award in Carbohydrate Chemistry: Synthesis as an Enabling Technology for Understanding Glycan Biosynthesis and Function |
| Chair: Amelia Rauter |
The ICO Young Researcher Award: GlycoTime: The Impact of the Circadian Glycome |
||
5 July 2026 – Welcome Reception |
|||
|
18:30–21:00 |
|||
6 July 2026 |
|||
6 July 2026 – Plenary Session 1 |
|||
|
Drama Hall |
Chair: David Crich |
08:45–09:30 |
PL1: Advancing sialo glycan synthesis: Chemical strategies driving biological insight |
|
09:30–10:15 |
PL2: High-throughput glycomics of health and diseases |
||
|
10:15–10:45 |
Coffee Break |
||
6 July 2026 – Parallel Session 1 |
|||
|
Drama Hall |
Synthesis of carbohydrates and glycoconjugates |
||
| Chair: Hiromune Ando |
10:45–11:15 |
IL1: Can Sugars Play the Role of Proteins? Biomimetic Assemblies and Molecular Machinery with Cyclodextrins |
|
|
11:15–11:30 |
OC1: Synthetic Peptidoglycan Substrates as Chemical Tools to Probe and Target Bacterial Transglycosylases |
||
|
11:30–11:45 |
OC5: Selective Functionalization of Levoglucosan and Analogues for the Synthesis of Structurally Relevant Carbohydrates |
||
|
11:45–12:00 |
OC9: Streamline carbohydrates synthesis through new methods and strategeis |
||
|
12:00–12:15 |
OC13: N-sulfonyl azalevoglucosan, a versatile platform for the diversity-oriented synthesis of iminosugars |
||
|
12:15–12:30 |
OC17: TBA |
||
|
12:30–14:00 |
Lunch |
||
Synthesis of carbohydrates and glycoconjugates |
|||
| Chair: Xuewei Liu |
14:00–14:30 |
IL5: Chemical Synthesis of Oligosaccharide Repeating Units of ESKAPE Pathogens |
|
|
14:30–14:45 |
OC21: Chemoenzymatic synthesis of selectively fluorinated HIV-1 glycopeptides and antibodies for probing biological functions |
||
|
14:45–15:00 |
OC25: Harnessing Commensal Lipid Architecture: Toward Immunomodulatory glycolipids inspired by Bacteroides fragilis Lipid A |
||
|
15:00–15:15 |
OC29: Mapping the Glycosylation Mechanism of 3,6-Anhydro-Galactosides for the Synthesis of Defined Agarose Fragments and Probes |
||
|
15:15–15:30 |
OC33: Stirring through glycopeptide synthesis misconceptions |
||
|
15:30–15:45 |
OC37: Organometallic marriage of sugars with porphyrins – new strategies towards glycoporphyrins |
||
|
15:45–16:15 |
Coffee Break |
||
Synthesis of carbohydrates and glycoconjugates |
|||
| Chair: Pavla Bojarová |
16:15–16:45 |
IL9: Hydrogen-bond-mediated Aglycone Delivery |
|
|
16:45–17:00 |
OC41: Glycomimetics as Chemical Tools to Study α(1→3)-Fucosyltransferases |
||
|
17:00–17:15 |
OC45: First Total Synthesis of a structurally Complex Conjugation-ready Tetrasaccharide RU of Vibrio cholerae O:3 O-antigen |
||
|
17:15–17:30 |
OC49: Bio- and organocatalysis in the key steps for the synthesis of glycomimetics with potential biological activity |
||
|
17:30–17:45 |
OC53: Swainsonine-based iminosugars as selective inhibitors of Golgi α-mannosidase II |
||
|
17:45–18:00 |
OC57: Automated synthesis of monosaccharide building blocks and applications in oligosaccharide synthesis |
||
6 July 2026 – Parallel Session 2 |
|||
|
Studio |
Glycans & Health |
||
| Chair: Nikolay Nifantiev |
10:45–11:15 |
IL2: The ADP-heptose/ALPK1 innate immune pathway: from antibacterial defense to antitumor immunity |
|
|
11:15–11:30 |
OC2: Glycans as potential targets for novel cancer immunotherapeutic approaches |
||
|
11:30–11:45 |
OC6: Nanomedicine targeting pancreatic cancer cell surface neuraminidase-1 |
||
|
11:45–12:00 |
OC10: Development of carbohydrate based vaccines |
||
|
12:00–12:15 |
OC14: Chemical tools for the precision targeting of the Golgi organelle in cancer |
||
|
12:15–12:30 |
OC18: Glycomimetic collectin-11 antagonists as a tool to study lectin-mediated ischemic injury during kidney transplantation |
||
|
12:30–14:00 |
Lunch |
||
Glycans & Health |
|||
| Chair: Winfried Römer |
14:00–14:30 |
IL6: Development of automated systems for glycodiagnostics |
|
|
14:30–14:45 |
OC22: GlycoNMR: Fast Quantification of Plasma N-glycosylation Profiles Associated to Cancer Progression and Inflammatory Processes by NMR |
||
|
14:45–15:00 |
OC26: Targeting Tumour-Associated Glycans via Macrophage Galactose C-Type Lectin (MGL): From Molecular Recognition to Glycan-Directed Cancer Therapies |
||
|
15:00–15:15 |
OC30: Luminescent glycoconjugate complexes and materials as sensors for bacterial lectins, and associated antiadhesive properties |
||
|
15:15–15:30 |
OC34: Unravelling the glycan recognition properties of human galectin-9 |
||
|
15:30–15:45 |
OC38: Machine learning–based identification of IgG N-glycan biomarkers in inflammatory bowel disease |
||
|
15:45–16:15 |
Coffee Break |
||
Glycans & Health / Synthesis |
|||
| Chair: Antoni Planas |
16:15–16:45 |
IL10: Impact of Glycosylation on Biotherapeutic Drugs |
|
|
16:45–17:00 |
OC42: Exploring the molecular dynamics of Heparan Sulfate and Chondroitin Sulfate expression in gastric cancer |
||
|
17:00–17:15 |
OC46: The two polymers behind one false identity, a new perspective on Aspergillus fumigatus biofilms. |
||
|
17:15–17:30 |
OC50: Hydroxybenzoic Galactosides as Potent LecA Inhibitors: From SAR Studies to an Anti-Adhesive Prodrug Strategy. |
||
|
17:30–17:45 |
OC54: Human blood group glycosyltransferases GTA and GTB in the synthesis of blood group antigens |
||
|
17:45–18:00 |
OC58: Covalent Oseltamivir Aziridines as Mechanism-Based Inhibitors and Probes of Influenza Neuraminidase |
||
6 July 2026 – Parallel Session 3 |
|||
|
Opera Lounge |
Glycobiology & Glycomics |
||
| Chair: Elisa Fadda |
10:45–11:15 |
IL3: Chemical tools for quantifying glycosidase activities directly within cells and their application to uncovering disease biology |
|
|
11:15–11:30 |
OC3: Metabolic Glycoengineering for Studying Protein O-GlcNAcylation and the Vestibular Organ of Zebrafish |
||
|
11:30–11:45 |
OC7: When pathogens read sugars: Unraveling microbial lectins |
||
|
11:45–12:00 |
OC11: Recent Advances in Glycosaminoglycan Microarrays: Illuminating New Nodes in the GAG Interactome |
||
|
12:00–12:15 |
OC15: Identification of genes encoding DLO-PP’ase |
||
|
12:15–12:30 |
OC19: Comprehensive Characterization of Glycoproteins on the Cell Surface and Their Dynamics using Mass Spectrometry-Based Proteomics |
||
|
12:30–14:00 |
Lunch |
||
Glycobiology & Glycomics |
|||
| Chair: Yan Liu |
14:00–14:30 |
IL7: GlycoChat: Decoding Glycan–Lectin Circuits in Pancreatic Cancer at Single-Cell Resolution |
|
|
14:30–14:45 |
OC23: Understanding the Mucus degradation Machinery by Employing Synthetic Mucin Tandem Repeat Glycopeptides |
||
|
14:45–15:00 |
OC27: Time and dose-depended Protues mirabilis S1959(O3) lipopolysaccharide endotoxicity, evaluated on Galleria mellonella larvae model |
||
|
15:00–15:15 |
OC31: 19F-tagged galectins to monitor glycan binding in complex environments |
||
|
15:15–15:30 |
OC35: Advancing Glycomics and Glycoproteomics by LC–MS: Resolving Glycan Isomers and Enabling Multi-Omics Biomarker Discovery |
||
|
15:30–15:45 |
OC39: Serotype-Specific Streptococcus pneumoniae Modulates Tumor-Associated Macrophages and PD-L1 Expression in Lung Cancer |
||
|
15:45–16:15 |
Coffee Break |
||
Glycobiology & Glycomics / Biochemistry of Carbohydrates |
|||
| Chair: Manfred Wuhrer |
16:15–16:45 |
IL11: Development and application of C-type lectin ligands for targeted delivery |
|
|
16:45–17:00 |
OC43: Structure and function of peptidoglycan O-acetyltransferase A, an integral membrane acyltransferase |
||
|
17:00–17:15 |
OC47: Detection of meningioma serum glycobiomarker using Ulex europaeus agglutinin-I |
||
|
17:15–17:30 |
OC51: Scalable Enzymatic Synthesis of Free-Reducing Human Milk Oligosaccharides via a β-Galactosidase-Resistant Tagging Strategy |
||
|
17:30–17:45 |
OC55: Elucidation of N-linked glycans recognition mechanism of endo-β-N-acetylglucosaminidase from Coprinopsis cinerea: Focusing on core and aglycone structures |
||
|
17:45–18:00 |
OC59: Study of a thermophilic GH3 β-glucosidase from Rhodothermus marinus and the role of its non-catalytic domains in biomass degradation |
||
6 July 2026 – Parallel Session 4 |
|||
|
Blue Lounge |
Glycomaterials |
||
| Chair: Antony Fairbanks |
10:45–11:15 |
IL4: Pectin Aerogels: transforming a conventional polysaccharide into high-performance materials |
|
|
11:15–11:30 |
OC4: Synthesis and Functional Properties of Fatty Acid Derivatives of Maltobionic Acid and Oxidized Dextrin: Oil Gelation and Collagen Production |
||
|
11:30–11:45 |
OC8: Depletion of sulfate moieties from polysaccharides derived from Porphyridium cruentum using an electric method |
||
|
11:45–12:00 |
OC12: Photoswitchable Azobenzene-bridged Ionizable Amphiphilic Janus Glycosides: en route to Spatio-Temporal Control of Nucleic Acid Delivery |
||
|
12:00–12:15 |
OC16: Preparation, characterization and anticancer activity of β-cyclodextrin nanosponges formulated with two chemotherapeutic drugs |
||
|
12:15–12:30 |
OC20: Regio- and Stereoselective Synthesis of the Biotin-Conjugated Keratan Sulfate Hexa- and Octasaccharide in the Repeating Disaccharide Region |
||
|
12:30–14:00 |
Lunch |
||
Bioinformatics & Molecular modelling |
|||
| Chair: Miloš Hricovíni |
14:00–14:30 |
IL8: AI assisted identification of low-energy conformers of mono- and di-saccharides and comparison with experimental vibrational spectra |
|
|
14:30–14:45 |
OC24: Deciphering the 3D Antigenic Landscape of Staphylococcus aureus Capsular Polysaccharides through Molecular Modelling |
||
|
14:45–15:00 |
OC28: When flexible glycans meet flexible proteins: what we have learnt by applying FTIR-spectroscopy and computer modelling to complexes with sulfated polysaccharides |
||
|
15:00–15:15 |
OC32: The distinct binding of typical and atypical LPS to toll-like receptors 2 and 4. A computational exploration |
||
|
15:15–15:30 |
OC36: PapayaDB: A Web-Based Database of Cathepsin–GAG in silico Interactions |
||
|
15:30–15:45 |
OC40: Substrate Scope and Synthetic Utility of an α1,3/4-Fucosyltransferase from Bacteroides fragilis |
||
|
15:45–16:15 |
Coffee Break |
||
Glycomaterials |
|||
| Chair: Francesco Nicotra |
16:15–16:45 |
IL12: Convergent assembly and study of glycosylated cyclodextrins and glycosurfaces |
|
|
16:45–17:00 |
OC44: Engineering Multivalent Mannose Interfaces for Biointerfacial Recognition and Biomedical Applications |
||
|
17:00–17:15 |
OC48: Olive stone-derived polysaccharide-based biofilms for food and cosmetic applications |
||
|
17:15–17:30 |
OC52: Evaluation of Binding Affinity for Laminin with Matriglycan Oligosaccharides and the Dendrimers |
||
|
17:30–17:45 |
OC56: Photoinitiated 1,2-cis addition to 2-alkoxyglycals – stereoselective route to thioglycosides and glycosylazoles with interesting properties |
||
|
17:45–18:00 |
OC60: Four of a kind: chemical synthesis of nonulosonic acid-containing Acinetobacter baumannii K-glycans |
||
7 July 2026 |
|||
7 July 2026 – Plenary Session 2 |
|||
|
Drama Hall |
Chair: Biao Yu |
08:45–09:30 |
PL3: A Sweet Surprise: miRNA regulation of the glycome |
|
09:30–10:15 |
PL4: On Oxo- and dioxocarbenium ions and their roles in glycosylation reactions |
||
|
10:15–10:45 |
Coffee Break |
||
7 July 2026 – Parallel Session 5 |
|||
|
Drama Hall |
Structural analysis |
||
| Chair: Jesus Jimenez Barbero |
10:45–11:15 |
IL13: The Essence of Polysaccharides |
|
|
11:15–11:30 |
OC61: Are N-Linked glycans intrinsically disordered? |
||
|
11:30–11:45 |
OC65: Content and Location of 3-O-Sulfated Glucosamine. Structural Determinants Differentiating Ovine Heparin from Bovine and Porcine Heparins |
||
|
11:45–12:00 |
OC69: Glycan receptor specificities of human viruses |
||
|
12:00–12:15 |
OC73: Structural insights into Man9 recognition by the HIV antibody 2G12 revealed by paramagnetic NMR |
||
|
12:15–12:30 |
OC77: Glycoprotein analysis with MALDI-DIT in MS¹, MS², and MS³ |
||
|
12:30–14:00 |
Lunch |
||
Synthesis of carbohydrates and glycoconjugates |
|||
| Chair: Carme Rovira |
14:00–14:30 |
IL17: Sulfur-mediated Routes to Bioactive Glycan Analogues |
|
|
14:30–14:45 |
OC81: How to improve pharmacokinetics of glycoconjugates in vivo |
||
|
14:45–15:00 |
OC85: Visible Light-Induced Synthesis of 2-Deoxy Sugars |
||
|
15:00–15:15 |
OC89: Linkage-Editing of β-Glucosylceramide by β-Selective C-Glucosylation Generates Potent Mincle Ligands |
||
|
15:15–15:30 |
OC93: Synthesis of Streptococcus pneumoniae 6A/6C Oligosaccharides for Vaccine Applications |
||
|
15:30–17:30 |
Poster Session (Foyer) |
||
Synthesis of carbohydrates and glycoconjugates |
|||
| Chair: Anikó Borbás |
17:30–17:45 |
OC97: Tertiary N-Galactopyranosylbenzamides as Potent and High Selective Glycomimetic Inhibitors of Galectin-3 |
|
|
17:45–18:00 |
OC101: Synthetic approaches towards tetrasaccharide fragments of secondary cell wall polysaccharides containing pyruvylated ß-ᴅ-ManNAc units |
||
|
18:00–18:15 |
OC105: Copper(II) Trifluoromethanesulfonate as an Efficient, Versatile, and Dual-Purpose Catalyst for the Regioselective Acetylation of ʟ-Sorbose under Neat and Solvent-Directed Conditions |
||
|
18:15–18:30 |
OC109: Design and Synthesis of Covalent Cholera Toxin Ligands |
||
7 July 2026 – Parallel Session 6 |
|||
|
Studio |
Glycans & Health |
||
| Chair: Mark von Itzstein |
10:45–11:15 |
IL14: Host glycans trap bacterial lectins to activate the NLRP3 inflammasome |
|
|
11:15–11:30 |
OC62: Glycolipids of pathogenic microbes: Synthesis and evaluations for their structure-immunomodulating activities |
||
|
11:30–11:45 |
OC66: The Parkinson's Disease Drug Tolcapone and Analogues are Potent Glycomimetic Lectin Inhibitors of Pseudomonas aeruginosa LecA |
||
|
11:45–12:00 |
OC70: Targeting a bacterial lectin with non-covalent and covalent beta-fucosylamides |
||
|
12:00–12:15 |
OC74: Structural modeling of α-1,2- or α-1,3-branched exopolysaccharides via enzymatic modification to modulate digestion properties |
||
|
12:15–12:30 |
OC78: Structural variability of the LPS-molecule from a pan-drug-resistance Pseudomonas aeruginosa isolate |
||
|
12:30–14:00 |
Lunch |
||
Glycans & Health |
|||
| Chair: Feng Shao |
14:00–14:30 |
IL18: Microwave-based Glycosylation Methodology Assists in Immunotherapeutic Development |
|
|
14:30–14:45 |
OC82: Engineering resistant starch-enriched banana starches via enzymatic chain elongation enhances short-chain fatty acid production during gut fermentation. |
||
|
14:45–15:00 |
OC86: Polysaccharides from Streptococcus and Serratia are tumor hemorrhagic and are the probable API’s of Coley’s toxin: On PS1, the Serratia constituent |
||
|
15:00–15:15 |
OC90: Pectins from Agri-Food By-Products Extracted with NADES: Structure - Function Relationships in Glycaemic and Gut Health |
||
|
15:15–15:30 |
OC94: Instruct-ERIC: Funded Access to Technologies for Structural Biology and Carbohydrate Research |
||
|
15:30–17:30 |
Poster Session (Foyer) |
||
Glycans & Health |
|||
| Chair: Vladimír Křen |
17:30–17:45 |
OC98: Biocatalytic modification of microbial-derived reuteran regulates intestinal fermentation kinetics and improves the colonic environment |
|
|
17:45–18:00 |
OC102: Characterization of UipB protein from Microbacterium ViU2A |
||
|
18:00–18:15 |
OC106: Stereoselective synthesis and selective antiphage activity of carbohydrate-derived δ-thiolactones |
||
|
18:15–18:30 |
OC110: Sweet targets: Exploring the glycosylation of nucleoside analogue therapeutics |
||
7 July 2026 – Parallel Session 7 |
|||
|
Opera Lounge |
Biochemistry of carbohydrates |
||
| Chair: Ed Yates |
10:45–11:15 |
IL15: New chemical tools for carbohydrate modifying enzymes |
|
|
11:15–11:30 |
OC63: Microbial sulfosugar metabolism: Uptake, pathways and C–S bond cleavage |
||
|
11:30–11:45 |
OC67: Peptidoglycan deaceylases of Bacillus subtilis. Specificities and applications acting on chitooligosaccharides. |
||
|
11:45–12:00 |
OC71: Cross-chiral recognition in glycobiology |
||
|
12:00–12:15 |
OC75: Structural basis for core α1,3-fucosylated N-glycan recognition by a PNGase A |
||
|
12:15–12:30 |
OC79: ER endomannosidase triages misfolded glycoproteins from calnexin/calreticulin folding cycle |
||
|
12:30–14:00 |
Lunch |
||
Structural analysis |
|||
| Chair: Ana Arda |
14:00–14:30 |
IL19: Sugars in the Gas Phase – Mass Spectrometry-Based Tools to Unravel the Glycocode |
|
|
14:30–14:45 |
OC83: Unravelling the Complexity of Hyaluronic Acid: How Molecular Structure Affects Physicochemical Properties |
||
|
14:45–15:00 |
OC87: Structural Elucidation of an Arabinogalactan from Neltuma nigra Resin Featuring Unusual β-(1→2)-Linked Arabinofuranosyl Residues |
||
|
15:00–15:15 |
OC91: Deciphering the Structure and Catalytic Mechanism of the Carbohydrate-active enzyme GH43 β-1,4-Xylosidase from Pseudopedobacter saltans |
||
|
15:15–15:30 |
OC95: Structural analysis and mechanism of action of oligofructofuranosyl DFA III producing endo-inulin fructotransferase from Bacteroides cacao |
||
|
15:30–17:30 |
Poster Session (Foyer) |
||
Structural analysis |
|||
| Chair: Marco Guerrini |
17:30–17:45 |
OC99: Structural characterization of starch and β-glucan from diverse barley lines |
|
|
17:45–18:00 |
OC103: Structure-Collision Cross Section (CCS) Correlation and MS/MS Fragmentation Features of Neutral Human Milk Oligosaccharides Isomers Characterized by Ion Mobility Spectrometry-Mass Spectrometry |
||
|
18:00–18:15 |
OC107: Comprehensive characterization of apolipoprotein E by liquid chromatography – mass spectrometry |
||
|
18:15–18:30 |
OC111: Stereoselective Synthesis of Matriglycan Anomeric Isomers and the Evaluation of the Laminin-Binding Affinity |
||
7 July 2026 – Parallel Session 8 |
|||
|
Blue Lounge |
Glycoconjugates |
||
| Chair: Yukari Fujimoto |
10:45–11:15 |
IL16: Engineering Glycan Recognition at Membranes: From Model Glycocalyces to Lectin Based Fusogens |
|
|
11:15–11:30 |
OC64: Linear and cyclic antifreeze glycoprotein analogues as structurally defined platforms for structure–activity relationship studies |
||
|
11:30–11:45 |
OC68: Genome-guided discovery of glycosylated antimalarial cyclolipodepsipeptides |
||
|
11:45–12:00 |
OC72: Chimerolectins: the emerging important lectins |
||
|
12:00–12:15 |
OC76: Organoruthenium Thiodigalactoside Glycomimetics Reverse Galectin Selectivity and Block Tumor Immune Evasion |
||
|
12:15–12:30 |
OC80: Vaccine architecture shapes the quality and breadth of antibody responses elicited by Klebsiella pneumoniae carbohydrate-based vaccines |
||
|
12:30–14:00 |
Lunch |
||
Biochemistry of carbohydrates |
|||
| Chair: Christoph Rademacher |
14:00–14:30 |
IL20: β-D-glucuronides of dietary phenols; tools for probing biological activity. |
|
|
14:30–14:45 |
OC84: GPR55 Modulation: Conformational Determinants and Electrophile-Substituted Lysophospholipid Analogues as Non-Competitive Antagonists |
||
|
14:45–15:00 |
OC88: Ligand-directed chemistry profiling of glycosidases |
||
|
15:00–15:15 |
OC92: Rewiring Fungal Rutinosidases: Glycone Promiscuity and Side-Tunnel Engineering Enable Designer Transglycosylation |
||
|
15:15–15:30 |
OC96: A tandem sulfofucolytic/sulfolytic pathway for the catabolism of the rare sulfosugar, sulfofucose. |
||
|
15:30–17:30 |
Poster Session (Foyer) |
||
Glycoconjugates |
|||
| Chair: Bruce Turnbull |
17:30–17:45 |
OC100: Monoglycosylceramides as Immunomodulators and Adjuvants for Infectious Diseases |
|
|
17:45–18:00 |
OC104: Frameshift Mapping and Acetylation Surrogate Enable Structure-Defined Vaccine Epitopes from Klebsiella pneumoniae K1 CPS |
||
|
18:00–18:15 |
OC108: Development of a Modular Synthetic Strategy for Peptidoglycan Fragments |
||
|
18:15–18:30 |
OC112: Synthesis of oxazole modified glycoconjugates as potential beta-glucosidase Inhibitors |
||
7 July 2026 – Cultural Event |
|||
|
St. Martin‘s Cathedral |
20:00–21:30 |
||
8 July 2026 |
|||
8 July 2026 – Plenary Session 3 |
|||
|
Drama Hall |
Chair: Lara Mahal |
08:45–09:30 |
PL5: Targetting clinically relevant sialic acid-recognising respiratory viruses. From in silico and synthesis to in vitro and in vivo studies. |
|
09:30–10:15 |
PL6: Deciphering enzymatic glycosylation mechanisms |
||
|
10:15–10:45 |
Coffee Break |
||
8 July 2026 – Parallel Session 9 |
|||
|
Drama Hall |
Synthesis of carbohydrates and glycoconjugates |
||
| Chair: Suvarn S. Kulkarni |
10:45–11:15 |
IL21: Exploitation of photoinitiated thiol-ene reaction for the synthesis of lectin inhibitors |
|
|
11:15–11:30 |
OC113: Scope and Mechanism of Protonated Phenanthroline-Catalyzed Stereoselective Glycosylation and Applications to the Synthesis of Vaccine Adjuvants |
||
|
11:30–11:45 |
OC117: Exploration of sialic acid aldolases reveals the Corynebacterium glutamicum enzyme as a highly effective biocatalyst for the synthesis of the bacterial ‘sialic acid-like’ sugars |
||
|
11:45–12:00 |
OC121: Glyco-oxazolinium cation: generation, structure, properties |
||
|
12:00–12:15 |
OC125: A few complex bacterial oligosaccharides synthesis and vaccines development |
||
|
12:15–13:45 |
Lunch |
||
8 July 2026 – Parallel Session 10 |
|||
|
Studio |
Glycans & Health |
||
| Chair: Peter R. Andreana |
10:45–11:15 |
IL22: Restoring Glycan Homeostasis: Therapeutic Convergence of Cancer Immunobiology and CDG |
|
|
11:15–11:30 |
OC114: Targeting GBA2 and GCS via PROTACs: HiBiT-Enabled Discovery of Dual GBA2/GCS Degraders |
||
|
11:30–11:45 |
OC118: Targeting Mycobacterium tuberculosis GlgE: Novel Inhibitors for Antimicrobial Discovery |
||
|
11:45–12:00 |
OC122: Design and Synthesis of 1-O- and 6′-C-Modified Heparan Sulfate Trisaccharides as Human Endo-6-O-Sulfatase 1 Inhibitors |
||
|
12:00–12:15 |
OC126: Improving the Weak Mincle-Activating Activity of 6,6’-diacyl neotrehalose by Linkage-Editing |
||
|
12:15–13:45 |
Lunch |
||
8 July 2026 – Parallel Session 11 |
|||
|
Opera Lounge |
Structural analysis |
||
| Chair: Zbigniew Kaczynski |
10:45–11:15 |
IL23: Engineering Synthetic Heparanase Inhibitors: Antimetastatic Properties and Mechanistic Basis. |
|
|
11:15–11:30 |
OC115: A Workflow For Comprehensive Structural Determination of Fructans and Raffinose Family Oligosaccharides |
||
|
11:30–11:45 |
OC119: Molecular insights into GD3 recognition by human coronavirus spike proteins |
||
|
11:45–12:00 |
OC123: Structural Insights into Dolichol Biosynthesis by the Human cis-Prenyltransferase Complex |
||
|
12:00–12:15 |
OC127: Metabolic inactivation or bioactivation: glucuronides of diosgenin as an antifungal agents |
||
|
12:15–13:45 |
Lunch |
||
8 July 2026 – Parallel Session 12 |
|||
|
Blue Lounge |
Glycobiology & Glycomics |
||
| Chair: David Vocadlo |
10:45–11:15 |
IL24: Heterogeneity in Glycoprotein Structure and Function: Regulation of N-glycans Macroheterogeneity by OST |
|
|
11:15–11:30 |
OC116: Decoding Glycan Regulation and Display at the Cancer Cell Surface |
||
|
11:30–11:45 |
OC120: Preparation of 3,3-difluoro sialic acid and its testing as a sialyltransferase inhibitor |
||
|
11:45–12:00 |
OC124: Mapping evolution-driven human H3N2 influenza glycan-binding preferences by chemoenzymatic synthesis and NMR |
||
|
12:00–12:15 |
OC128: Introducing Fluorine into Disaccharide Lectin Ligands Enhances Binding Affinity and Selectivity |
||
|
12:15–13:45 |
Lunch |
||
8 July 2026 – Tours (External) |
|||
|
14:00 |
|||
9 July 2026 |
|||
9 July 2026 – Parallel Session 13 |
|||
|
Drama Hall |
Synthesis of carbohydrates and glycoconjugates |
||
| Chair: Cristina Nativi |
08:45–09:15 |
IL25: Synthetic strategies toward s-disaccharide glycomimetics with galectin-3 selectivity |
|
|
09:15–09:30 |
OC129: Synthetic Strategies for Building and Editing Nucleoside Analogues |
||
|
09:30–09:45 |
OC133: Glycomimetics-Multivalent Probes to Fight Antimicrobial Resistance |
||
|
09:45–10:00 |
OC137: Polyproline nanoscaffolds as tools to investigate carbohydrate interactions |
||
|
10:00–10:15 |
OC141: Enhancing lectin recognition via precise fluorination: new insights into DC-SIGN interactions |
||
|
10:15–10:30 |
OC145: Chemoenzymatic Synthesis of Sulfated Human Milk Oligosaccharide Derivatives Enabled by Differential Fucosylation of Sulfated Oligosaccharides |
||
|
10:30–11:00 |
Coffee Break |
||
Glycans & Health / Synthesis |
|||
| Chair: Celso Reis |
11:00–11:30 |
IL29: Exploitation of sugar chemistry against neurodegeneration |
|
|
11:30–11:45 |
OC149: The biological role of glycans in post-acute infection syndromes |
||
|
11:45–12:00 |
OC153: Glycosyl thioimidates as versatile building blocks for stereocontrolled glycosylation and glycan synthesis |
||
|
12:00–12:15 |
OC157: Targeting endo-D-arabinofuranosidases in mycobacteria as a novel therapeutic strategy |
||
|
12:15–12:30 |
OC161: Synthesis and Antiproliferative Activity of Fluorinated N-Acetylmannosamine Analogs |
||
|
12:30–12:45 |
OC165: GlycoExtreme: Unlocking Novel Hyperstable Glycosyltransferases |
||
|
12:45–14:00 |
Lunch |
||
Synthesis of carbohydrates and glycoconjugates |
|||
| Chair: Matthieu Sollogoub |
14:00–14:15 |
OC169: Novel bacterial α2,3- and α2,6-sialyltransferases for efficient complex-glycan synthesis |
|
|
14:15–14:30 |
OC173: Synthesis of N-glycosides via Buchwald-Hartwig Coupling |
||
|
14:30–14:45 |
OC177: Convergent Synthesis of Branched Human Milk Oligosaccharides Enables Access to Fucosylated Probes for Viral Recognition |
||
|
14:45–15:00 |
OC181: De Novo Synthesis of 3,6-Dideoxy and 3,6-Dideoxy-4-C-branched Monosaccharides. |
||
|
15:00–15:15 |
OC185: Synthesis of Listeria Wall Teichoic Acids for Probing the Human Antibody Repertoire |
||
9 July 2026 – Parallel Session 14 |
|||
|
Studio |
Glycans & Health |
||
| Chair: Paula Videira |
08:45–09:15 |
IL26: New Glycosyltransferase Inhibitors Targeting the Biosynthesis of Cancer-Associated Glycans |
|
|
09:15–09:30 |
OC130: Synthetic Carbohydrate Receptors as Broad Spectrum Antivirals |
||
|
09:30–09:45 |
OC134: A Syalomimetic Glycan Array for the Identification of Viral Entry Inhibitors |
||
|
09:45–10:00 |
OC138: Synthesis of GroP-Modified Group A Carbohydrate Oligosaccharides for Immunological Studies |
||
|
10:00–10:15 |
OC142: Cell-selective Glycopolymer Modification via Peroxidase-mediated Proximity Labeling for Antibody-recruiting Cancer Immunotherapy |
||
|
10:15–10:30 |
OC146: Streamlined Synthesis and Immunomodulatory Effects of Ulvan Oligosaccharides from Marine Green Algae |
||
|
10:30–11:00 |
Coffee Break |
||
Structural analysis / Synthesis |
|||
| Chair: Kevin Pagel |
11:00–11:30 |
IL30: Structural studies of polysaccharides isolated from the cell wall of plant-pathogenic bacteria |
|
|
11:30–11:45 |
OC150: Characterization of protein-glycan interactions through advanced STD NMR methods |
||
|
11:45–12:00 |
OC154: Synthesis and Function of Acetobacter pasteurianus Lipid A |
||
|
12:00–12:15 |
OC158: Carbohydrate conjugates as trojan horses to improve antibiotic import |
||
|
12:15–12:30 |
OC162: Synthetic Approaches Toward Chain D of Rhamnogalacturonan-II: DHA Rare Sugar Preparation and β-Glycosylation Strategy |
||
|
12:30–12:45 |
OC166: Shelf-stable 3-thiocresyl-prop-1-enyl (TCP) glycosides in glycosylations |
||
|
12:45–14:00 |
Lunch |
||
Glycans & Health / Synthesis |
|||
| Chair: Peter Greimel |
14:00–14:15 |
OC170: Glycoproteomic profiling of Alzheimer’s disease brains reveals changes in bisecting GlcNAc carriers |
|
|
14:15–14:30 |
OC174: Design and Synthesis of Glycomimetics as Galectin Antagonists |
||
|
14:30–14:45 |
OC178: Fucose-Based Anti-Virulence Agents Targeting EclA, a Novel Lectin from Enterobacter cloacae |
||
|
14:45–15:00 |
OC182: Total Synthesis of Conjugation-Ready Sulfated Red Algae Carrageenan Oligosaccharides for Sensing Applications |
||
9 July 2026 – Parallel Session 15 |
|||
|
Opera Lounge |
Structural analysis |
||
| Chair: Alfred D. French |
08:45–09:15 |
IL27: Molecular Mechanisms of Glycan-Mediated Molecular Recognition |
|
|
09:15–09:30 |
OC131: CH-π interactions of pyranosides - chemical shift perturbations induced by arenes |
||
|
09:30–09:45 |
OC135: Development of a method to identify & quantify N-glycans from lactoferrins |
||
|
09:45–10:00 |
OC139: An Integrated CRISPR–NMR Platform for Glycoengineered Cell Models and Glycan Characterization |
||
|
10:00–10:15 |
OC143: Klebsiella pneumoniae O-antigens – correlation of novel OL loci with chemical structures |
||
|
10:15–10:30 |
OC147: Using Fourier-transformed alternating current voltammetry to detect and fingerprint glycans |
||
|
10:30–11:00 |
Coffee Break |
||
Glycobiology & Glycomics |
|||
| Chair: Valentin Wittmann |
11:00–11:30 |
IL31: Mass spectrometry in glycobiology: From glycan structure to clinical application |
|
|
11:30–11:45 |
OC151: Chemical tools to probe ribitol phosphate-containing glycans |
||
|
11:45–12:00 |
OC155: Structural characterization of the jacalin-related lectin from the mushroom Calocera viscosa |
||
|
12:00–12:15 |
OC159: Comparison of the Milk Oligosaccharide Spectrum in Farm Animals |
||
|
12:15–12:30 |
OC163: Mass spectrometry assisted N-glycan analysis of phosphorylated epitopes in simple organisms |
||
|
12:30–12:45 |
OC167: Mapping ST3GAL Transferase Specificities in the Glycosylation Landscape of N/TERT-1 Keratinocytes Using Glycogenomics and Mass Spectrometry |
||
| 12:45–14:00
|
Lunch |
||
Structural analysis / Synthesis |
|||
| Chair: Nicole Richardson |
14:00–14:15 |
OC171: Classification of pectins based on functional properties and structure analysis by MALDI-FTICR-MS |
|
|
14:15–14:30 |
OC175: Anomerization of glycosides by iminium salt formed in dibromomethane and dimethylformamide |
||
|
14:30–14:45 |
OC179: Polycationic cyclodextrin derivatives as antimicrobial agents: design, synthesis, and biological evaluation |
||
|
14:45–15:00 |
OC183: Advantages and benefits of total serum glycome analysis for cancer detection |
||
9 July 2026 – Parallel Session 16 |
|||
|
Blue Lounge |
Bioinformatics & Molecular modelling |
||
| Chair: Robert Woods |
08:45–09:15 |
IL28: Decrypting the "sulfation code" of glycosaminoglycans for understanding their function in the extracellular matrix |
|
|
09:15–09:30 |
OC132: GlycoFlow: A GlycoShape-Trained Conformational Prior for Structural Glycobiology |
||
|
09:30–09:45 |
OC136: Deciphering the molecular recognition code of S1 sulfatase towards sulfamate and sulfate substrates |
||
|
09:45–10:00 |
OC140: Molecular Simulations of Paenibacillus alvei Cell Wall Glycans and SpaA Anchoring |
||
|
10:00–10:15 |
OC144: Studies on applications of fully stereoselective α-sialylation |
||
|
10:15–10:30 |
OC148: HPLC-based automated oligosaccharide synthesis using TIDA-tagged monosaccharide building blocks |
||
|
10:30–11:00 |
Coffee Break |
||
Glycomaterials / Synthesis |
|||
| Chair: Tatiana Budtova |
11:00–11:30 |
IL32: Glycosylated ECM, AI/ML guided synthesis and cell fate modulation |
|
|
11:30–11:45 |
OC152: Modelling Multivalent Avidity in C-type lectins: Revealing how glycan surface density, composition and presentation govern superselective pathogen recognition by tetravalent DC-SIGN |
||
|
11:45–12:00 |
OC156: Surface grafting of carbohydrates on polymer materials via non-thermal plasma activation |
||
|
12:00–12:15 |
OC160: Reversible Functionalisation of Synthetic Cellulosic Oligosaccharides |
||
|
12:15–12:30 |
OC164: Chemoenzymatic Regioselective Manipulation of Acyl Groups on Carbohydrates: A Path towards Sustainable Carbohydrate Chemistry |
||
|
12:30–12:45 |
OC168: Synthesis of oligosaccharide fragments of rhamnogalacturonan-II side chain B |
||
|
12:45–14:00 |
Lunch |
||
Glycobiology & Glycomics |
|||
| Chair: Tanja Wrodnigg |
14:00–14:15 |
OC172: Understanding glycan recognition processes: NMR insights into the biologically relevant CD44–hyaluronan interaction |
|
|
14:15–14:30 |
OC176: Beyond Initial Analysis: Cross-Disease Profiling of the Human Blood N-Glycome Through Mass Spectrometry Data Re-analysis. |
||
|
14:30–14:45 |
OC180: New β-D-galactopyranosyl azoles: synthesis and evaluation as galectin-1 and galectin-3 inhibitors |
||
|
14:45–15:00 |
OC184: Synthesis of ENGase inhibitors for glycan recognition analysis |
||
|
15:15–15:45 |
Coffee Break |
||
9 July 2026 – Plenary Session 4 |
|||
|
Drama Hall |
Chair: Alexei Demchenko |
15:45–16:30 |
PL7: Expedient and catalytic strategies for the synthesis of glycan-based diagnostics |
|
16:30–17:15 |
PL8: A Personal Account on the Total Synthesis for Structural Validation of Natural Glycans and Glycoconjugates |
||
9 July 2026 – Closing Ceremony |
|||
|
Drama Hall |
17:15–17:45 |
||
9 July 2026 – Symposium Dinner |
|||
|
Dock 7 |
19:00–22:00 |
||
Last update on 25 June 2026.
The program might be subject to necessary changes.

